Measles immunization rate in Lithuania 2010-2022

Published by Statista Research Department, Oct 21, 2024
The immunisation of measles in Lithuania decreased by 1.9 percent of children aged less than one year (-2.15 percent) in 2022 in comparison to the previous year. Therefore, 2022 marks the lowest immunisation in this industry during the observed period.

Find more key insights for the immunisation in countries like Denmark, Norway, and Sweden.

Annual share of children immunized against measles in Lithuania from 2010 to 2022

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

August 2024

Region

Lithuania

Survey time period

2010 to 2022

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Vaccinations in Italy "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Vaccinations in Italy

Immunization coverage among children and adolescents

7

Immunization coverage trends among two-year-olds

8

Immunization coverage among two-year-olds by region

8

HPV vaccination

5

Flu vaccination

5

COVID-19 vaccine

5

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Vaccine hesitancy in the U.S.Pharmaceutical industry in the U.S.Geriatric health in the U.S.Children's health in the U.S.Diseases
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.